4B CEDAR BROOK DRIVE, CRANBURY, NJ
Earns €5.5 Million ($6.5 Million) Milestone Payment in Retinal Disease Collaboration
Other Events
To develop potential first-in-class melanocortin receptor targeted treatment for patients with retinal diseases
Amended material disclosure
Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws, Reg. FD
News
Annual Report to Security Holders
Q3
Q2
Q1
FY 2024
FY 2023
Amended Registration Statement for Securities
S-1
Prospectus filed pursuant to Rule 424(b)(4)
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(5)
PRE 14A
Definitive Proxy Statement
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Amended Statement of Changes in Beneficial Ownership
RW WD
Correspondence
Submission Upload